Breastcancer.org Podcast

340 Episodes

1. Trodelvy Offers Benefits for Hormone Receptor-Positive Breast Cancer

   Published: 9/21/2022
2. Enhertu for HER2-Low Breast Cancer: Patient-Reported Outcomes

   Published: 9/14/2022
3. Mental Health Benefits of Pets

   Published: 8/19/2022
4. How Therapy Can Help People Affected by Breast Cancer

   Published: 8/5/2022
5. Fezolinetant: A Non-Hormonal Treatment for Hot Flashes

   Published: 7/22/2022
6. Enhertu for HER2-Low Breast Cancer

   Published: 7/8/2022
7. Loosening COVID-19 Restrictions and Immunocompromised People: Do You Feel Left Behind?

   Published: 6/24/2022
8. Genetic and Genomic Tests: What’s the Difference?

   Published: 6/2/2022
9. Just Ask: Increasing Diversity in Clinical Trials

   Published: 5/27/2022
10. Dating and Breast Cancer

    Published: 4/29/2022
11. Adolescent and Young Adult Breast Cancer

    Published: 3/28/2022
12. Top Research Presented at the 2021 San Antonio Breast Cancer Symposium

    Published: 12/21/2021
13. Aromatase Inhibitors versus Tamoxifen for Pre-Menopausal Women Diagnosed With Early-Stage, Hormone Receptor-Positive Disease

    Published: 12/13/2021
14. Experimental Elacestrant: A Standard of Care for Pre-Treated, Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer?

    Published: 12/11/2021
15. Alcohol and Breast Cancer Risk

    Published: 11/5/2021
16. Breast Cancer Research at ESMO 2021

    Published: 10/21/2021
17. Kisqali Plus Femara Seems Best Option for Advanced-Stage Hormone-Receptor-Positive HER2-Negative Breast Cancer

    Published: 10/1/2021
18. Keytruda Added to Chemotherapy Improves Overall Survival for Metastatic PD-L1-Positive, Triple-Negative Breast Cancer

    Published: 9/24/2021
19. The Importance of Diversity in Breast Cancer Clinical Trials

    Published: 9/15/2021
20. Tattoo Ink Showing Up on Mammograms

    Published: 8/20/2021